Current Research Studies

Azithromycin treatment for RSV-induced Respiratory Failure in Children

ARRC

Phase: III
Clinicaltrials.gov ID: NCT05026749

What is the goal of the study?

The ARRC Trial is a multiyear, multicenter prospective, randomized, double-blinded, placebo-controlled phase III trial in RSV + pediatric patients < 24 months who are admitted to the pediatric intensive care unit (PICU) or step-down unit (SDU), designed to examine the efficacy of AZM therapy in reducing RSV-related morbidity.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Scott Watson
Study Team Member: Deana Rich, [email protected]